Cure My Disease

Don't miss your cure!

 Log in / Sign up

New cholesterol drug leqvio under Long-Term safety watch

NCT ID NCT06275724

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jan 07, 2026 · Last updated May 11, 2026 · Updated 19 times

Summary

This study is checking the long-term safety of a drug called Leqvio in people with very high cholesterol (familial hypercholesterolaemia) or high cholesterol. About 585 patients are being watched for side effects and how well the drug lowers their bad cholesterol. The goal is to make sure the drug is safe for long-term use.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FAMILIAL HYPERCHOLESTEROLAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Novartis Investigative Site

    Handa, Aichi-ken, 475-0817, Japan

  • Novartis Investigative Site

    Ichinomiya, Aichi-ken, 491-8551, Japan

  • Novartis Investigative Site

    Ichinomiya, Aichi-ken, 494-0001, Japan

  • Novartis Investigative Site

    Komaki, Aichi-ken, 485-8520, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 4540933, Japan

  • Novartis Investigative Site

    Nagoya, Aichi-ken, 461-0045, Japan

  • Novartis Investigative Site

    Toyoake, Aichi-ken, 4701192, Japan

  • Novartis Investigative Site

    Tsushima, Aichi-ken, 496-0038, Japan

  • Novartis Investigative Site

    Asahi, Chiba, 289-2511, Japan

  • Novartis Investigative Site

    Inzai, Chiba, 270-1694, Japan

  • Novartis Investigative Site

    Urayasu, Chiba, 279-0021, Japan

  • Novartis Investigative Site

    Matsuyama, Ehime, 791-8016, Japan

  • Novartis Investigative Site

    Fukui-shi, Fukui, 910-8526, Japan

  • Novartis Investigative Site

    Fukuoka, Fukuoka, 8140180, Japan

  • Novartis Investigative Site

    Fukuoka, Fukuoka, 815-0082, Japan

  • Novartis Investigative Site

    Kitakyushu, Fukuoka, 800-0031, Japan

  • Novartis Investigative Site

    Kitakyushu, Fukuoka, 8078556, Japan

  • Novartis Investigative Site

    Fukushima, Fukushima, 960-8611, Japan

  • Novartis Investigative Site

    Kōriyama, Fukushima, 963-8501, Japan

  • Novartis Investigative Site

    Shirakawa, Fukushima, 961-0005, Japan

  • Novartis Investigative Site

    Gifu, Gifu, 500-8384, Japan

  • Novartis Investigative Site

    Hiroshima, Hiroshima, 7320053, Japan

  • Novartis Investigative Site

    Kure, Hiroshima, 737-0023, Japan

  • Novartis Investigative Site

    Asahikawa, Hokkaido, 078-8214, Japan

  • Novartis Investigative Site

    Asahikawa, Hokkaido, 0788211, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0040052, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 0620003, Japan

  • Novartis Investigative Site

    Sapporo, Hokkaido, 065-0027, Japan

  • Novartis Investigative Site

    Amagasaki, Hyōgo, 660-8511, Japan

  • Novartis Investigative Site

    Himeji, Hyōgo, 670-8560, Japan

  • Novartis Investigative Site

    Kobe, Hyōgo, 654-0026, Japan

  • Novartis Investigative Site

    Ono, Hyōgo, 675-1327, Japan

  • Novartis Investigative Site

    Takarazuka, Hyōgo, 665-0873, Japan

  • Novartis Investigative Site

    Kamisu, Ibaraki, 314-0146, Japan

  • Novartis Investigative Site

    Koga, Ibaraki, 306-0232, Japan

  • Novartis Investigative Site

    Mito, Ibaraki, 310-0015, Japan

  • Novartis Investigative Site

    Moriya, Ibaraki, 302-0102, Japan

  • Novartis Investigative Site

    Tsukuba, Ibaraki, 3058576, Japan

  • Novartis Investigative Site

    Kagoshima, Kagoshima-ken, 890-8760, Japan

  • Novartis Investigative Site

    Fujisawa, Kanagawa, 252-0802, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 224-8503, Japan

  • Novartis Investigative Site

    Yokohama, Kanagawa, 235-0016, Japan

  • Novartis Investigative Site

    Yokosuka, Kanagawa, 239-8567, Japan

  • Novartis Investigative Site

    Yokosuka, Kanagawa, 240-0101, Japan

  • Novartis Investigative Site

    Yatsushiro, Kumamoto, 866-8533, Japan

  • Novartis Investigative Site

    Kyoto, Kyoto, 602-8566, Japan

  • Novartis Investigative Site

    Kyoto, Kyoto, 612-8555, Japan

  • Novartis Investigative Site

    Kyōtanabe, Kyoto, 610-0334, Japan

  • Novartis Investigative Site

    Tsu, Mie-ken, 514-8507, Japan

  • Novartis Investigative Site

    Nagasaki, Nagasaki, 8508555, Japan

  • Novartis Investigative Site

    Nagasaki, Nagasaki, 852-8055, Japan

  • Novartis Investigative Site

    Ōmura, Nagasaki, 856-8562, Japan

  • Novartis Investigative Site

    Ikoma, Nara, 636-0802, Japan

  • Novartis Investigative Site

    Kashihara, Nara, 634-0045, Japan

  • Novartis Investigative Site

    Tenri, Nara, 632-8552, Japan

  • Novartis Investigative Site

    Nagaoka, Niigata, 940-8621, Japan

  • Novartis Investigative Site

    Ōita, Oita Prefecture, 870-0263, Japan

  • Novartis Investigative Site

    Ōita, Oita Prefecture, 870-1133, Japan

  • Novartis Investigative Site

    Ōita, Oita Prefecture, 879-7761, Japan

  • Novartis Investigative Site

    Kurashiki, Okayama-ken, 7108602, Japan

  • Novartis Investigative Site

    Urasoe, Okinawa, 901-2102, Japan

  • Novartis Investigative Site

    Uruma, Okinawa, 904-2293, Japan

  • Novartis Investigative Site

    Izumisano, Osaka, 5988577, Japan

  • Novartis Investigative Site

    Moriguchi, Osaka, 570-8507, Japan

  • Novartis Investigative Site

    Osaka, Osaka, 5400006, Japan

  • Novartis Investigative Site

    Osaka, Osaka, 543-8922, Japan

  • Novartis Investigative Site

    Takatsuki, Osaka, 569-0852, Japan

  • Novartis Investigative Site

    Takatsuki, Osaka, 569-1121, Japan

  • Novartis Investigative Site

    Takatsuki, Osaka, 5698686, Japan

  • Novartis Investigative Site

    Toyonaka, Osaka, 560-0083, Japan

  • Novartis Investigative Site

    Asaka, Saitama, 3510021, Japan

  • Novartis Investigative Site

    Gyōda, Saitama, 361-0056, Japan

  • Novartis Investigative Site

    Iruma-gun, Saitama, 3500495, Japan

  • Novartis Investigative Site

    Kitamoto, Saitama, 364-8501, Japan

  • Novartis Investigative Site

    Sōka, Saitama, 340-0043, Japan

  • Novartis Investigative Site

    Tokorozawa, Saitama, 359-1142, Japan

  • Novartis Investigative Site

    Nagahama, Shiga, 526-8580, Japan

  • Novartis Investigative Site

    Izunokuni, Shizuoka, 410-2295, Japan

  • Novartis Investigative Site

    Mooka, Tochigi, 321-4306, Japan

  • Novartis Investigative Site

    Hachiōji, Tokyo, 192-0918, Japan

  • Novartis Investigative Site

    Machida, Tokyo, 194-0021, Japan

  • Novartis Investigative Site

    Meguro City, Tokyo, 153-8515, Japan

  • Novartis Investigative Site

    Minato, Tokyo, 106-0031, Japan

  • Novartis Investigative Site

    Nerima-ku, Tokyo, 176-8530, Japan

  • Novartis Investigative Site

    Shinjuku, Tokyo, 160-8488, Japan

  • Novartis Investigative Site

    Shinjuku Ku, Tokyo, 1628666, Japan

  • Novartis Investigative Site

    Sumida City, Tokyo, 130-8575, Japan

  • Novartis Investigative Site

    Toshima-ku, Tokyo, 171-0014, Japan

  • Novartis Investigative Site

    Takaoka, Toyama, 939-1104, Japan

  • Novartis Investigative Site

    Hashimoto, Wakayama, 648-0005, Japan

  • Novartis Investigative Site

    Sakata, Yamagata, 998-8501, Japan

  • Novartis Investigative Site

    Akita, 0108577, Japan

  • Novartis Investigative Site

    Chiba, 261-0024, Japan

  • Novartis Investigative Site

    Fukuoka, 811-0213, Japan

  • Novartis Investigative Site

    Fukushima, 9601295, Japan

  • Novartis Investigative Site

    Himeji, 671-1227, Japan

  • Novartis Investigative Site

    Ishikawa, 9208641, Japan

  • Novartis Investigative Site

    Kagoshima, 892-0853, Japan

  • Novartis Investigative Site

    Kumamoto, 861-4193, Japan

  • Novartis Investigative Site

    Kyoto, 6078062, Japan

  • Novartis Investigative Site

    Nara, 630-8581, Japan

  • Novartis Investigative Site

    Okayama, 7008558, Japan

  • Novartis Investigative Site

    Osaka, 543-8555, Japan

  • Novartis Investigative Site

    Osaka, 5458586, Japan

  • Novartis Investigative Site

    Osaka, 558-8558, Japan

  • Novartis Investigative Site

    Shizuoka, 422-8527, Japan

Conditions

Explore the condition pages connected to this study.

FAMILIAL HYPERCHOLESTEROLAEMIA HYPERCHOLESTEROLAEMIA